Related Experiment Video

Updated: Jun 7, 2026

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Hematology: Reduced-intensity induction therapy for elderly patients with multiple myeloma

Lisa Richards

    Nature Reviews. Clinical Oncology
    |November 5, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
    11:25

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

    Published on: April 1, 2015

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
    06:28

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

    Published on: November 10, 2023

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
    11:25

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

    Published on: April 1, 2015

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes.

    Gastro hep advances·2026

    Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines.

    The American journal of gastroenterology·2026

    Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

    Alimentary pharmacology & therapeutics·2026

    The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use.

    Gastroenterology·2026

    Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing.

    JHEP reports : innovation in hepatology·2026

    Clinical Utility of a 50% and 30% Decline in Magnetic Resonance Imaging-Proton Density Fat Fraction in Predicting Fibrosis Improvement in Metabolic Dysfunction-associated Steatohepatitis.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

    AI-based augmentation of oncology clinical trials.

    Nature reviews. Clinical oncology·2026

    Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

    Nature reviews. Clinical oncology·2026

    De-escalation trials in multiple myeloma: past, present and future.

    Nature reviews. Clinical oncology·2026

    Towards liquid biopsy-based analysis of antitumour immunity.

    Nature reviews. Clinical oncology·2026

    CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

    Nature reviews. Clinical oncology·2026

    Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

    Nature reviews. Clinical oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us